Page 2 - Target Validation News Today

/PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "Medical Linear Accelerator Market" The report offers an extensive...

Behcet’s Disease Treatment Market Size By Type (Ocular-Behcet, Vasculo-Behcet, and Neuro-Behcet), By Route of Administration (Oral and Injectable),...

Single-use Assemblies Market Size By Product (Filtration Assemblies, Bottle Assemblies, Bag Assemblies, Tubing Assemblies, and Others), By End-Use...

The Air France-KLM Group and its airlines are committed to reducing their environmental footprint as part of a transparent and responsible approach to...

FreightWeek - Insights on sustainable business practices for the global logistics industry

/PRNewswire/ -- Allied Market Research published a report, titled, "Drug Discovery Outsourcing Market by Workflow (Target Identification and Screening, Target...

Toronto, ON (PRWEB) October 11, 2022 -- Many clinical trials fail due to inadequately distinguishing between disease phenotypes and underlying drivers of

Toronto, ON (PRWEB) October 03, 2022 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical

Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi that endangers almost 70 million people worldwide. The only two drugs that are currently approved for its treatment, benznidazole and nifurtimox, have controversial efficacy in adults and restricting safety issues, leaving thousands of patients without a suitable treatment. The neglect of Chagas disease is further illustrated by the lack of a robust and diverse drug discovery and development portfol...

New substance suppresses the growth of harmful bacteria that cause periodontitis Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous. It was developed and tested for the first time by a team from Martin Luther University Halle-Wittenberg (MLU), the Fraunhofer Institute for Cell Therapy and Immunology IZI and Periotrap Pharmaceuticals GmbH. The aim is to neutralize only bacteria that cause periodon...